Radgocitabine | Interleukin Related interleukin-related.com

Product Name :
Radgocitabine

Search keywords :
CNDAC

drugId :
null

Target Vo:
DNA-directed DNA polymerase

Target Vo Short Name :
DNA-directed DNA polymerase

Moa_Name:
DNA-directed DNA polymerase inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Delta-Fly Pharma Inc

Active Company_Name :
Delta-Fly Pharma Inc

Active Indication_Name:
Leukemia, Myeloid, Acute

In Active Indication_Name:
Precursor Cell Lymphoblastic Leukemia-Lymphoma

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
PDIA2 Rabbit mAb Protocol
Adipose Triglyceride Lipase Rabbit mAb Epigenetics
MMP7 Antibody: MMP7 Antibody is an unconjugated, approximately 30 kDa, rabbit-derived, anti-MMP7 polyclonal antibody. MMP7 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, and predicted: rat background without labeling.

Author: Interleukin Related

Related Posts